US 9528094
Attenuated African swine fever virus vaccine based in the deletion of MGF genes
granted A61KA61K2039/5254A61K2039/552
Quick answer
US patent 9528094 (Attenuated African swine fever virus vaccine based in the deletion of MGF genes) held by The United States of America, as represented by the Secretary of Agriculture expires Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary of Agriculture
- Grant date
- Tue Dec 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K2039/5254, A61K2039/552, A61K39/12